First Trust Advisors LP Astrazeneca PLC Transaction History

First Trust Advisors LP

$95 Billion
Q2 2024

A detailed history of First Trust Advisors LP transactions in Astrazeneca PLC stock. As of the latest transaction made, First Trust Advisors LP holds 870,741 shares of AZN stock, worth $66.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

870,741

Previous 1,231,576 29.3%

Holding current value

$66.2 Million

Previous $83.4 Million 18.61%

% of portfolio

0.07%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $24.1 Million - $29.2 Million	-360,835 Reduced 29.3%	870,741 $67.9 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $9.73 Million - $11.1 Million	-159,383 Reduced 11.46%	1,231,576 $83.4 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $5.92 Million - $6.63 Million	95,652 Added 7.38%	1,390,959 $93.7 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $1.5 Million - $1.66 Million	23,182 Added 1.82%	1,295,307 $87.7 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $3.29 Million - $3.56 Million	-46,994 Reduced 3.56%	1,272,125 $91 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $3.94 Million - $4.47 Million	62,462 Added 4.97%	1,319,119 $91.6 Million
Q4 2022 Feb 09, 2023	SELL	$54.21 - $70.44 $12.9 Million - $16.7 Million	-237,279 Reduced 15.88%	1,256,657 $85.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $18.7 Million - $47.8 Million	352,198 Added 30.85%	1,493,936 $81.9 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $2.44 Million - $2.93 Million	-41,223 Reduced 3.48%	1,141,738 $75.4 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $6.36 Million - $7.67 Million	114,231 Added 10.69%	1,182,961 $78.5 Million
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $3.34 Million - $3.94 Million	61,772 Added 6.13%	1,068,730 $62.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $73,505 - $80,425	1,323 Added 0.13%	1,006,958 $60.5 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $6.09 Million - $7.57 Million	-125,805 Reduced 11.12%	1,005,635 $60.2 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $2.4 Million - $2.78 Million	50,994 Added 4.72%	1,131,440 $56.3 Million
Q4 2020 Feb 02, 2021	BUY	$48.52 - $58.02 $52.4 Million - $62.7 Million	1,080,446 New	1,080,446 $54 Million
Q3 2020 Nov 05, 2020	SELL	$53.07 - $61.1 $223,636 - $257,475	-4,214 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$43.1 - $55.31 $29,437 - $37,776	-683 Reduced 13.95%	4,214 $223,000
Q1 2020 May 06, 2020	SELL	$37.79 - $51.33 $32,159 - $43,681	-851 Reduced 14.81%	4,897 $219,000
Q4 2019 Feb 03, 2020	BUY	$42.46 - $50.46 $244,060 - $290,044	5,748 New	5,748 $287,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $236B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Astrazeneca PLC Transaction History